CIMB Reiterates Reduce Rating for Sirtex Medical Limited (SRX)
Sirtex Medical Limited (ASX:SRX) traded down 0.85% on Tuesday, hitting A$18.610. 100,487 shares of the company’s stock traded hands. Sirtex Medical Limited has a 52 week low of A$10.780 and a 52 week high of A$19.380. The stock’s 50-day moving average is A$17.66 and its 200-day moving average is A$15.94. The company has a market cap of A$1.044 billion and a P/E ratio of 49.53.
Separately, analysts at Morningstar reiterated a “hold” rating on shares of Sirtex Medical Limited in a research note on Sunday, April 27th.
Sirtex Medical Limited is a biotechnology and medical device company. The Company is engaged in manufacturing and distribution of liver cancer treatments utilizing small particle technology to approved markets in Asia-Pacific, Europe and Middle East and North and South America.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.